Home
Innovating Health
Bridging Science
Daehan Nupharm’s research institutes consist of the Central Research Institute,
Bio Research Institute, and VET Lab, working closely together based on their respective expertise.
Bridging Science
Central Research Institute
It focuses on developing specialty and general medicines for various diseases including wellness drugs, improving formulation technology, and developing improved new drugs with high value added to enhance treatment efficiency and patient convenience. It continuously invests in and researches various formulations such as long-acting injectables using DSPT (Delayed-Release Platform Technology) and oral peptide drugs using absorption improvement technologies (DDS, LNP).
R&D Vision
The Central Research Institute continues to grow as a research institution that leads the healthcare industry of the future by continuously introducing competitive products of superior quality, backed by expert researchers and advanced equipment.
Core Growth Drivers
New Drugs
and administration,
Expansion of indications,
Reduction of side effects, etc.
Mid- to Long-Term Growth Drivers
Improved
New Drugs
sustained-release
microparticles, etc.
generic
formulations, etc.
Future Growth Drivers
New Drugs
on new substances, etc.
through networks
R&D Goals
superior pharmaceuticals
a global pharmaceutical company
Functional natural product drug discovery
Development of new technologies to reduce side effects
Securing absorption improvement platform technologies
Strengthening global networks
Development of global new drugs
